Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $28.6600 (3.65%) ($27.6300 - $30.6000) on Thu. Aug. 9, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.28% (three month average) | RSI | 16 | Latest Price | $28.6600(3.65%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -7.5% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(62%) XBI(61%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -1.64% in a week (0% probabilities). VXX(-13%) VIXM(-12%) TLT(-5%) GDXJ(-5%) SHY(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.64% (StdDev 3.28%) | Hourly BBV | 0 () | Intraday Trend | 3.5% | | | |
|
1 - 5 Day Possible Target | $9.5(-66.85%) | Resistance Level | $31.76 | 5 Day Moving Average | $28.58(0.28%) | 10 Day Moving Average | $29.04(-1.31%) | 20 Day Moving Average | $31.76(-9.76%) | To recent high | -30.1% | To recent low | 3.7% | Market Cap | $1.78b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |